For novices and pumpers
Even though Aristotle launches in early 2021, the share price will never go above $1.50. And before Aristotle earns enough to raise the share price, if Aristotle earns anything, it will take years. Just looking at the money made with other szls products in the last few years. This company is a disgrace to investors, the cancer industry and the TSX.